Yucca Health vs MedVi: Pricing, meds, and support compared
Quick verdict: For lower ongoing compounded semaglutide and a tirzepatide option, Yucca Health is more budget-focused; for a promotional first month and 24/7 certified support, MedVi emphasizes an easy entry. This Yucca Health vs MedVi comparison lays out the key differences so you can decide which fits your priorities.
View Yucca Health pricing and plans
Top differences at a glance
This comparison focuses on the most distinctive supported differences: pricing structure and promos, medication options, approval and shipping speed, ongoing support and clinical model, and regulatory status. The aim is to compare Yucca Health and MedVi directly on points the sources supply.
1. Pricing structure and promos
Yucca Health advertises compounded semaglutide starting at $146/month and compounded tirzepatide from $258/month, with a 6-month semaglutide plan at $875 that yields a lower effective monthly rate. Yucca also promotes a Lifetime Price Lock code. MedVi highlights a promotional first month at $179 including fast, free shipping but notes ongoing standalone months rise to $299 and a three-month plan at $649 (about $216/month). The difference is simple: Yucca lists lower baseline monthly rates and multi-month plan pricing, while MedVi emphasizes an introductory promo with higher ongoing pricing.
2. Medication options: semaglutide only vs semaglutide and tirzepatide
Yucca Health offers both compounded semaglutide and compounded tirzepatide, the latter activating GIP and GLP-1 receptors and noted on the source as linked to higher average weight loss in research. MedVi provides clinically dosed compounded semaglutide only; it does not offer tirzepatide according to the sourced material. If having a tirzepatide pathway on the same platform matters, Yucca Health is the supported option here.
3. Approval timeline and shipping
Yucca Health reports fast online approval typically within 24 hours, an intake that takes about 10 minutes, and UPS 2-Day Air shipping with most patients receiving first shipment within 3 to 5 business days after intake completion. MedVi touts a simple online intake with no clinic visits and fast, free shipping for the promotional month. Both use an online clinician review process; Yucca specifically states typical 24-hour approvals and UPS 2-Day Air fulfillment.
4. Clinical support and ongoing care
MedVi emphasizes 24/7 support from certified medical professionals and a straightforward program including physician review, a personalized plan, 1:1 guidance, and a metabolic report. Yucca Health highlights personalized treatment plans based on health history, ongoing provider support, and dosage adjustments. Both platforms rely on licensed clinicians to determine medical appropriateness and prescribe compounded GLP-1 medications subject to clinician review.
5. Regulatory and product notes
Both sources include the regulatory caution that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Yucca’s materials state medications are filled at licensed U.S. compounding pharmacies and that compounded semaglutide uses the same active ingredient as branded products but is not FDA-reviewed as a compounded product. MedVi likewise notes compounded medications are not FDA-approved and encourages discussion with providers about risks and benefits.
| Criteria | Yucca Health | MedVi |
|---|---|---|
| Starting semaglutide price | $146/month | $179 first-month promo |
| Ongoing month price | Lower multi-month rates; 6-month plan $875 | $299 standalone month; 3-month plan $649 |
| Tirzepatide available | Yes, from $258/month | No, semaglutide only |
| Approval and shipping | Online intake ~10 minutes; decision within 24 hours; UPS 2-Day Air | Simple online intake; fast, free shipping for promo |
| Support model | Ongoing provider support and dosage adjustments | 24/7 certified medical support and 1:1 guidance |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-approved |
How to choose between Yucca Health and MedVi
Yucca Health vs MedVi comes down to priorities supported by the sources. If ongoing cost and access to tirzepatide matter, the sourced evidence supports Yucca Health. If an introductory promotional price and round-the-clock certified support are your focus, MedVi is positioned on those points.
Compare Yucca Health plans and options
Check MedVi promotional details
Explore Yucca Health tirzepatide availability
Final thoughts on Yucca Health vs MedVi
Both platforms are licensed telehealth providers offering compounded GLP-1 medications with online clinician review, and both note compounded medications are not FDA-approved. The sourced evidence draws a clear tradeoff: Yucca Health supports lower advertised recurring rates and offers a tirzepatide pathway, while MedVi highlights a lower first-month promo and 24/7 certified support but higher ongoing month pricing.
Choose Yucca Health if you prioritize lower multi-month pricing and access to both compounded semaglutide and tirzepatide. Choose MedVi if you prioritize a low promotional first month, simple intake with no clinic visits, and 24/7 certified support.